Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
JP Stock MarketDetailed Quotes
6191 AirTrip
- 1105
- +35+3.27%
20min DelayMarket Closed Jan 9 15:30 JST
24.74BMarket Cap12.33P/E (Static)
1112High1057Low212.90KVolume1058Open1070Pre Close232.38MTurnover190652wk High1.50%Turnover Ratio22.39MShares92052wk Low89.62EPS TTM15.71BFloat Cap4595Historical High12.33P/E (Static)14.22MShs Float517Historical Low89.62EPS LYR5.14%Amplitude10.00Dividend TTM1.80P/B100Lot Size0.90%Div YieldTTM
AirTrip Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 13.62%26.57B | -7.14%6.09B | 27.15%6.4B | 72.10%23.39B | 31.52%6.63B | 71.11%5.16B | 175.23%6.56B | 60.07%5.03B | -22.45%13.59B | 51.65%5.04B |
| Cost of revenue | 12.00%11.04B | -15.65%2.64B | 1.99%2.61B | 64.04%9.86B | -6.32%2.43B | 52.99%1.74B | 202.13%3.12B | 106.45%2.56B | -39.36%6.01B | 89.08%2.6B |
| Gross profit | 14.80%15.53B | 0.61%3.45B | 53.22%3.79B | 78.49%13.53B | 71.61%4.2B | 82.07%3.42B | 154.60%3.43B | 29.92%2.47B | -0.46%7.58B | 25.28%2.45B |
| Operating expense | 8.64%12.64B | 6.18%2.82B | 30.72%2.67B | 104.88%11.64B | 107.82%3.99B | 64.53%2.96B | 181.53%2.65B | 99.22%2.04B | 7.17%5.68B | 28.81%1.92B |
| Selling and administrative expenses | 14.77%12B | 10.96%2.83B | 27.34%2.68B | 58.93%10.46B | 54.51%2.96B | 57.30%2.83B | 94.52%2.55B | 36.11%2.11B | 23.92%6.58B | 38.41%1.92B |
| -General and administrative expense | 14.77%12B | 10.96%2.83B | 27.34%2.68B | 58.93%10.46B | 54.51%2.96B | 57.30%2.83B | 94.52%2.55B | 36.11%2.11B | 23.92%6.58B | 38.41%1.92B |
| Other operating expenses | -50.65%761M | ---- | -97.06%1M | 588.39%1.54B | 3,120.00%1.13B | --241M | -9.74%139M | -10.53%34M | -44.96%224M | -87.89%35M |
| Total other operating income | -67.31%118M | -56.10%18M | -87.63%12M | -67.85%361M | 202.94%103M | 2,280.00%119M | -92.19%41M | -82.68%97M | 169.95%1.12B | -81.62%34M |
| Operating profit | 52.67%2.89B | -18.33%637M | 160.89%1.11B | -0.42%1.89B | -59.43%215M | 457.14%468M | 92.12%780M | -51.26%427M | -17.93%1.9B | 13.98%530M |
| Net non-operating interest income (expenses) | -920.00%-459M | 44.00%-14M | -2,209.09%-464M | 78.97%-45M | 123.91%11M | 24.64%-52M | 59.68%-25M | 161.11%22M | -116.16%-214M | 0.00%-46M |
| Non-operating interest income | 58.97%62M | --1M | -97.50%1M | 290.00%39M | 440.00%27M | ---- | ---- | 1,233.33%40M | -76.74%10M | 131.25%5M |
| Non-operating interest expense | 520.24%521M | -40.00%15M | 2,483.33%465M | -62.50%84M | -68.63%16M | -25.71%52M | -60.32%25M | -53.85%18M | 57.75%224M | 70.00%51M |
| Net investment income | -612.37%-497M | -199.32%-146M | -56.89%97M | -1,047.37%-872M | 283.97%599M | 182.69%147M | 7.66%225M | 81.19%-76M | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -170.00%-21M | -83.33%1M | 225.00%13M | -75.00%30M | -59.57%19M | -95.83%1M | -83.78%6M | -63.64%4M | 605.88%120M | 840.00%47M |
| Special income (charges) | 81.53%403M | 143.96%222M | ||||||||
| Less:Other special charges | ---- | -81.53%-403M | ---- | ---- | ---- | ---- | -143.96%-222M | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -3.19%1.91B | 4.48%1.03B | -13.98%517M | -2.81%1.97B | -238.02%-628M | 418.37%1.02B | 107.17%982M | -33.59%601M | -33.29%2.03B | 1,720.00%455M |
| Income tax | -115.23%-133M | -2.88%236M | 25.93%238M | 116.63%873M | -54.00%23M | 391.76%418M | 155.79%243M | 9.25%189M | -23.67%403M | 198.04%50M |
| Net income | 85.90%2.04B | 6.90%790M | -32.28%279M | -32.41%1.1B | -261.14%-651M | 438.74%598M | 94.99%739M | -43.64%412M | -35.32%1.63B | 431.58%404M |
| Net income continuous operations | 85.90%2.04B | 6.90%790M | -32.28%279M | -32.41%1.1B | -261.14%-651M | 438.74%598M | 94.99%739M | -43.64%412M | -35.32%1.63B | 431.58%404M |
| Noncontrolling interests | 116.67%29M | 360.00%13M | -4.76%40M | -102.33%-174M | -48.57%-52M | -269.77%-159M | 77.27%-5M | 200.00%42M | -160.56%-86M | 61.11%-35M |
| Net income attributable to the company | 58.01%2.01B | 4.30%776M | -35.68%238M | -25.58%1.27B | -236.45%-599M | 392.21%758M | 85.54%744M | -48.40%370M | -27.82%1.71B | 164.46%439M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 58.01%2.01B | 4.30%776M | -35.68%238M | -25.58%1.27B | -236.45%-599M | 392.21%758M | 85.54%744M | -48.40%370M | -27.82%1.71B | 164.46%439M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 56.96%89.97 | 3.40%34.7 | -36.17%10.66 | -25.92%57.32 | -236.54%-27.09 | 388.13%34.12 | 85.11%33.56 | -48.50%16.7 | -31.00%77.38 | 178.65%19.84 |
| Diluted earnings per share | 58.84%89.62 | 4.67%34.55 | -35.34%10.61 | -25.67%56.42 | -239.14%-27.09 | 389.65%33.59 | 85.55%33.01 | -48.00%16.41 | -30.67%75.9 | 177.75%19.47 |
| Dividend per share | 0.00%10 | 0 | 0 | 0.00%10 | 0.00%10 | 0 | 0 | 0 | 0.00%10 | 0.00%10 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |